Cigna Corporation Financial Statements (CI)
|
|
|
|
Report date
|
|
|
24.02.2022 |
23.02.2023 |
29.02.2024 |
27.02.2025 |
26.02.2026 |
|
30.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
174 069 |
180 518 |
195 265 |
247 121 |
274 952 |
|
277 944 |
|
Operating Income, bln rub |
|
|
7 941 |
8 450 |
8 536 |
9 417 |
9 129 |
|
9 516 |
|
EBITDA, bln rub |
? |
|
9 963 |
10 436 |
10 846 |
11 446 |
11 607 |
|
11 931 |
|
Net profit, bln rub |
? |
|
5 370 |
6 704 |
5 164 |
3 434 |
5 957 |
|
6 288 |
|
|
OCF, bln rub |
? |
|
7 191 |
8 656 |
11 813 |
10 363 |
9 601 |
|
8 812 |
|
CAPEX, bln rub |
? |
|
1 154 |
1 295 |
1 573 |
1 406 |
1 212 |
|
1 152 |
|
FCF, bln rub |
? |
|
6 037 |
7 361 |
10 240 |
8 957 |
8 389 |
|
7 660 |
|
Dividend payout, bln rub
|
|
|
1 341 |
1 384 |
1 450 |
1 567 |
1 611 |
|
1 616 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
|
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
25.0% |
20.6% |
28.1% |
45.6% |
27.0% |
|
25.7% |
|
|
OPEX, bln rub |
|
|
15 010 |
15 050 |
16 641 |
16 547 |
16 857 |
|
16 334 |
|
Cost of production, bln rub |
|
|
151 118 |
157 018 |
170 088 |
221 157 |
248 966 |
|
252 094 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
1 208 |
1 228 |
1 446 |
1 435 |
1 381 |
|
1 376 |
|
|
Assets, bln rub |
|
|
154 889 |
143 885 |
152 761 |
155 881 |
157 919 |
|
153 266 |
|
Net Assets, bln rub |
? |
|
47 112 |
44 872 |
46 223 |
41 033 |
41 713 |
|
42 210 |
|
Debt, bln rub |
|
|
34 265 |
31 553 |
30 930 |
31 972 |
31 463 |
|
30 900 |
|
Cash, bln rub |
|
|
6 001 |
6 829 |
8 747 |
8 215 |
7 676 |
|
7 852 |
|
Net debt, bln rub |
|
|
28 264 |
24 724 |
22 183 |
23 757 |
23 787 |
|
23 048 |
|
|
Ordinary share price, rub |
|
|
229.6 |
|
|
276.1 |
275.2 |
|
280.8 |
|
Number of ordinary shares, mln |
|
|
338.0 |
313.1 |
296.9 |
280.3 |
265.9 |
|
262.5 |
|
|
Market cap, bln rub |
|
|
77 606 |
0 |
0 |
77 400 |
73 197 |
|
73 711 |
|
EV, bln rub |
? |
|
105 870 |
24 724 |
22 183 |
101 157 |
96 984 |
|
96 759 |
|
Book value, bln rub |
|
|
-35 610 |
-36 279 |
-31 717 |
-35 580 |
-31 771 |
|
-30 642 |
|
|
EPS, rub |
? |
|
15.9 |
21.4 |
17.4 |
12.3 |
22.4 |
|
24.0 |
|
FCF/share, rub |
|
|
17.9 |
23.5 |
34.5 |
32.0 |
31.5 |
|
29.2 |
|
BV/share, rub |
|
|
-105.4 |
-115.9 |
-106.8 |
-126.9 |
-119.5 |
|
-116.7 |
|
|
EBITDA margin, % |
? |
|
5.72% |
5.78% |
5.55% |
4.63% |
4.22% |
|
4.29% |
|
Net margin, % |
? |
|
3.08% |
3.71% |
2.64% |
1.39% |
2.17% |
|
2.26% |
|
FCF yield, % |
? |
|
7.78% |
|
|
11.6% |
11.5% |
|
10.4% |
|
ROE, % |
? |
|
11.4% |
14.9% |
11.2% |
8.37% |
14.3% |
|
14.9% |
|
ROA, % |
? |
|
3.47% |
4.66% |
3.38% |
2.20% |
3.77% |
|
4.10% |
|
|
P/E |
? |
|
14.5 |
0.00 |
0.00 |
22.5 |
12.3 |
|
11.7 |
|
P/FCF |
|
|
12.9 |
0.00 |
0.00 |
8.64 |
8.73 |
|
9.62 |
|
P/S |
? |
|
0.45 |
0.00 |
0.00 |
0.31 |
0.27 |
|
0.27 |
|
P/BV |
? |
|
-2.18 |
0.00 |
0.00 |
-2.18 |
-2.30 |
|
-2.41 |
|
EV/EBITDA |
? |
|
10.6 |
2.37 |
2.05 |
8.84 |
8.36 |
|
8.11 |
|
Debt/EBITDA |
|
|
2.84 |
2.37 |
2.05 |
2.08 |
2.05 |
|
1.93 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.66% |
0.72% |
0.81% |
0.57% |
0.44% |
|
0.41% |
|
| Cigna Corporation shareholders |
